| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 06/03/2004 | WO2004045549A2 Medical devices employing novel polymers |
| 06/03/2004 | WO2004045545A2 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 06/03/2004 | WO2004045537A2 Edible film for relief of cough or symptoms associated with pharyngitis |
| 06/03/2004 | WO2004045532A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/03/2004 | WO2004045522A2 Absolute quantitation of nucleic acids by rt-pcr |
| 06/03/2004 | WO2004045517A2 Method for the diagnosis and treatment of vascular disease |
| 06/03/2004 | WO2004045516A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2004 | WO2004045511A2 Non-steroidal farnesoid x receptor modulators |
| 06/03/2004 | WO2004045509A2 Method of using a cox-2 inhibitor and a 5-ht1a receptor modulator as a combination therapy |
| 06/03/2004 | WO2004045505A2 Extract of stephaniae sinica diels and methods of using the same |
| 06/03/2004 | WO2004026236A3 Cyclopentyl indole derivatives |
| 06/03/2004 | WO2004024084A9 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2003032995A8 Rosuvastatin in pre demented states |
| 06/03/2004 | US20040106896 System and method for forming a non-ablative cardiac conduction block |
| 06/03/2004 | US20040106826 Process for synthesizing L--methylene glutamic acid and analogs |
| 06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 06/03/2004 | US20040106554 polypeptide analogs of myelin basic protein for treatment of multiple sclerosis |
| 06/03/2004 | US20040106547 glucose lowering protein (GLP-1); exendins; for regulation of excess levels of blood glucose and/or regulation of gastric emptying; for treatment of diabetes and eating disorders |
| 06/03/2004 | US20040106098 Using spectrum analysis to monitor and partition active pharmeceutical ingredients (API) which are highly viscous and in high concentrations; drug screening and interactions |
| 06/03/2004 | US20040105902 Compositions and methods for treating prostate cancer |
| 06/03/2004 | US20040105887 Controlled release oxycodone compositions |
| 06/03/2004 | US20040105881 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 06/03/2004 | US20040105855 Compries immunoglobulin which binds tumor necrosis factor receptor and functions as antitumor agent in the treatment of cancer |
| 06/03/2004 | US20040105831 Compositions having a pearl blend appearance additive, personal care products made therefrom |
| 06/03/2004 | US20040103902 Condom with an erectogenic composition |
| 06/03/2004 | CA2506696A1 Method for the prevention of malaria |
| 06/03/2004 | CA2505994A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/03/2004 | CA2505992A1 Absolute quantitation of nucleic acids by rt-pcr |
| 06/03/2004 | CA2505922A1 Cytomodulating peptides for treating interstitial cystitis |
| 06/03/2004 | CA2505833A1 Edible film for relief of cough or symptoms associated with pharyngitis |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/02/2004 | EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 06/02/2004 | EP1423124A2 Lyophilized formulation comprising olanzapine |
| 06/02/2004 | EP1423101A1 Plaster for the treatment of dysfunctions and disorders of nails |
| 06/02/2004 | EP1114032B1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/02/2004 | EP1007008B1 Compositions for treating pulmonary disorders using optically pure (s)-salmeterol |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501793A Improved skin composition |
| 06/02/2004 | CN1500784A New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts ofranelic acid and thei |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1151841C Application of interferons(IFN) in preparation of pharmaceutics for stimulation of defence mechanism or immune reaction |
| 06/02/2004 | CN1151777C Preparation for transport of active substance across barriers |
| 06/02/2004 | CN1151772C Composition for use in oral cavity |
| 06/01/2004 | US6743442 Bioavailability; sustained release |
| 05/27/2004 | WO2004044227A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | WO2004043407A2 Methods and products for treating staphylococcal infections |
| 05/27/2004 | WO2004043401A2 Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use |
| 05/27/2004 | WO2004043388A2 Chewing gum with encapsulated stain removing agent |
| 05/27/2004 | WO2004043386A2 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | WO2004043384A2 Novel pharmacophore for the discovery and testing of na, k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions |
| 05/27/2004 | WO2004043383A2 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | WO2004043379A2 Chemical compounds |
| 05/27/2004 | WO2004043372A2 Boron coated straw neutron detector |
| 05/27/2004 | WO2004043369A2 Sulfonamides |
| 05/27/2004 | WO2004043367A2 Fused heterocyclic compounds and use thereof |
| 05/27/2004 | WO2004043362A2 Acyl guanidine compounds and use thereof |
| 05/27/2004 | WO2004043354A2 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | WO2004043353A2 Compositions and methods for treating acute myeloid leukemia |
| 05/27/2004 | WO2004043350A2 PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR α4/PAXILLIN BINDING |
| 05/27/2004 | WO2004043349A2 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 05/27/2004 | WO2004043346A2 Compositions containing an active fraction isolated from lycium barbarum and methods of using the same |
| 05/27/2004 | WO2004043345A2 Extract of trapa natans and methods of using the same |
| 05/27/2004 | WO2004043344A2 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | WO2004043340A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 05/27/2004 | WO2004043339A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 05/27/2004 | WO2004043336A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 05/27/2004 | WO2004043333A2 Bone enhancing composite |
| 05/27/2004 | WO2004028521A3 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 05/27/2004 | WO2004026254A3 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 05/27/2004 | WO2003045310A8 Digital assay |
| 05/27/2004 | US20040102650 Reacting hexachloroacetone with solvent-suspended resin-bound triphenylphosphine, chlorinating retinoic acid to provide retinoyl chloride, then stirring in pyridine; chromatography; for induction of apoptosis in cancer cells |
| 05/27/2004 | US20040102414 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/27/2004 | US20040102395 Modulation of IAP-like expression |
| 05/27/2004 | US20040102357 Functional fragrance precursor |
| 05/27/2004 | US20040101902 Contacting an agent with a cell-free system which contains PPAR-gamma, permits the expression of early growth response gene-1 and inhibits such expression in presence of PPAR-gamma agonist, stimulating cell free system to increase Egr-1 |
| 05/27/2004 | US20040101854 Modulation of BCL2-associated athanogene expression |
| 05/27/2004 | US20040101581 Chinese herbs extract |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | US20040101501 Mixture of water, oil and emulsifier |
| 05/27/2004 | CA2505546A1 Molecules preferentially associated with effector t cells and methods of their use |
| 05/27/2004 | CA2505537A1 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | CA2505127A1 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | CA2505003A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 05/27/2004 | CA2504953A1 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | CA2504818A1 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | CA2497401A1 Chewing gum and confectionary compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 05/26/2004 | EP1421083A1 Novel imidazopyridine compounds with therapeutic effect |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420799A2 Use of atazanavir in hiv therapy |
| 05/26/2004 | EP1173176B1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 05/26/2004 | EP1117652B1 Tan-1057 derivatives |
| 05/26/2004 | EP1015433B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1499955A Kits for whitening teeth |
| 05/26/2004 | CN1150901C Use of 1-ar (alk)yl-imidazoline-2-one for treating anxietyand stress conditions |
| 05/26/2004 | CN1150895C Dry Powder for inhalation |
| 05/26/2004 | CN1150884C Method for eeliminating scabriculous and/or wrinkle and compsn. |